Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by pennyDoctoron Oct 08, 2013 1:58am

87 Views

Post# 21798421

RE:RE:Patent is not Fluorination process

Thanks for the clarification. Your response was more than the normal rhetoric. I am sure as some read your explanation there were eyes spinning and minds swimming trying to grasp the organic chemistry of replacing O with F in a glycosides to create a stable hybrid that is worth millions from a molecule that wasn't worth 1 dollar. This continues to stack the future in Sironas favor. I have looked at TFC Chem's website but as you say it could be out of date since being aquired by Sirona. Take the vacation, I am sure there will be the normal ups and downs until the market grasps what this thing is actually worth from Mile stone payments to future revenue streams.

Bullboard Posts

A Look into the Future of Chronic Pain Management